Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis. von Sevan N Alwan, Alexander B Taylor, Jayce Rhodes, Michael Tidwell, Stanton F McHardy, Philip T LoVerde

Volltext

Rational approach to drug discovery for human schistosomiasis von Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy JC. Anderson, Stanton F. McHardy

Volltext

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] von Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy Jc Anderson, Stanton F. McHardy

Volltext

Schistosome Sulfotransferases: Mode of Action, Expression and Localization von Meghan A. Guzman, Anastasia Rugel, Sevan N. Alwan, Reid Tarpley, Alexander B. Taylor, Frédéric D. Chevalier, George R. Wendt, James J. Collins, Timothy J. C. Anderson, Stanton F. McHardy, Philip T. LoVerde

Volltext

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans. von Meghan A Guzman, Anastasia R Rugel, Reid S Tarpley, Sevan N Alwan, Frédéric D Chevalier, Dmytro P Kovalskyy, Xiaohang Cao, Stephen P Holloway, Timothy J C Anderson, Alexander B Taylor, Stanton F McHardy, Philip T LoVerde

Volltext